Identical Placebo

OTHER5 trials

Sponsors

Mayo Clinic, Regional Hospital of Scranton, Massachusetts General Hospital, University of Kansas Medical Center, Melius Pharma AB

Conditions

Atrial FibrillationChronic CoughCoughCoughingFatty LiverFibrotic Lung DiseaseIPFIdiopathic Pulmonary Fibrosis

Phase 2

Betaine in Patients With Nonalcoholic Steatohepatitis

CompletedNCT00586911

Mayo ClinicNonalcoholic Steatohepatitis

Start: 2003-01-31End: 2006-06-30Updated: 2015-04-08

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

CompletedNCT03375788

Massachusetts General HospitalFatty Liver, Liver Fat, Non-Alcoholic Fatty Liver Disease +2

Start: 2019-01-17End: 2025-01-10Updated: 2025-11-20

Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)

Active, not recruitingNCT05983471

Melius Pharma ABChronic Cough, Cough, Coughing +3

Start: 2024-04-01End: 2025-09-30Target: 40Updated: 2025-04-09

Phase 3

Vitamin C and Atrial Fibrillation After Cardiac Surgery

WithdrawnNCT01580683

Regional Hospital of ScrantonAtrial Fibrillation

Start: 2012-07-31End: 2015-08-31Updated: 2015-05-13

Unknown Phase

Evaluating the Tolerability and Effects of Berberine on Major Metabolic Biomarkers: A Pilot Study

CompletedNCT03976336

University of Kansas Medical CenterMetabolic Syndrome

Start: 2019-08-20End: 2025-04-01Updated: 2025-04-04